Hu, Qiwei, Yammani, Rama D., Brown-Harding, Heather, Soto-Pantoja, David R., Poole, Leslie B., and Lukesh, John C. Mitigation of doxorubicin-induced cardiotoxicity with an H2O2-Activated, H2S-Donating hybrid prodrug. Retrieved from https://par.nsf.gov/biblio/10335602. Redox Biology 53.C Web. doi:10.1016/j.redox.2022.102338.

Hu, Qiwei, Yammani, Rama D., Brown-Harding, Heather, Soto-Pantoja, David R., Poole, Leslie B., & Lukesh, John C. Mitigation of doxorubicin-induced cardiotoxicity with an H2O2-Activated, H2S-Donating hybrid prodrug. Redox Biology, 53 (C). Retrieved from https://par.nsf.gov/biblio/10335602. https://doi.org/10.1016/j.redox.2022.102338

Hu, Qiwei, Yammani, Rama D., Brown-Harding, Heather, Soto-Pantoja, David R., Poole, Leslie B., and Lukesh, John C. "Mitigation of doxorubicin-induced cardiotoxicity with an H2O2-Activated, H2S-Donating hybrid prodrug". Redox Biology 53 (C). Country unknown/Code not available. https://doi.org/10.1016/j.redox.2022.102338. https://par.nsf.gov/biblio/10335602.

@article{osti_10335602,
place = {Country unknown/Code not available}, title = {Mitigation of doxorubicin-induced cardiotoxicity with an H2O2-Activated, H2S-Donating hybrid prodrug}, url = {https://par.nsf.gov/biblio/10335602}, DOI = {10.1016/j.redox.2022.102338}, abstractNote = {}, journal = {Redox Biology}, volume = {53}, number = {C}, author = {Hu, Qiwei and Yammani, Rama D. and Brown-Harding, Heather and Soto-Pantoja, David R. and Poole, Leslie B. and Lukesh, John C.}, }